{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Ridgefield",
      "state": "CT",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82310",
      "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "address_1": "900 Ridgebury Rd",
      "address_2": "N/A",
      "postal_code": "06877-1058",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0991-2019",
      "product_description": "Mirapex (pramipexole dihydrochloride) Tablets, 1 mg, 100-count unit-dose tablets per folding carton, Rx only, Distributed by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT  06877 USA, Made in Germany, NDC 0597-0190-61.",
      "product_quantity": "112 folding cartons",
      "reason_for_recall": "Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.",
      "recall_initiation_date": "20190307",
      "center_classification_date": "20190311",
      "termination_date": "20190911",
      "report_date": "20190320",
      "code_info": "Lot # AA3280A, Exp SEP 2019"
    }
  ]
}